Vayas360 lands $25 million lead investment from AND Capital Ventures

By AI, Created 8:41 PM UTC, May 28, 2026, /AGP/ – Vayas360 said it secured a $25 million lead investment commitment from AND Capital Ventures to support the first close of its raise and an acquisition-led push to build a personalized health platform. The company is targeting a Food Is Medicine Coalition-accredited nutrition operator as its first step toward an integrated care ecosystem.

Why it matters: - Vayas360 is trying to assemble a broader personalized health platform through acquisitions, not just launch a single product. - The $25 million lead commitment is expected to anchor the first close of the current round and fund the company’s next phase of growth. - The strategy points to rising investor interest in healthspan, longevity, and data-driven care models that connect diagnostics to outcomes.

What happened: - Vayas360 announced a $25 million lead investment commitment from AND Capital Ventures on May 28, 2026. - The announcement came in San Diego during the Institute for Functional Medicine’s Annual International Conference. - Vayas360 said the capital will support its acquisition-led strategy to build a full-spectrum personalized health platform centered on the individual. - Vayas360 is pursuing the acquisition of a Food Is Medicine Coalition-accredited medically tailored nutrition operator with established payer relationships and accredited therapeutic programs.

The details: - Vayas360 said that acquisition would be the first operational layer in a larger plan to build an integrated ecosystem. - The company said its platform will combine diagnostics, genomic testing, microbiome analysis, therapeutic nutrition, personalized supplementation, wearable and biometric integration, health coaching, digital tools, and practitioner-guided support. - Vayas360 said the system is designed to move users from insight to action and generate longitudinal health and outcomes data over time. - The company uses the term “Vayaspan” to describe the personalized span of life where energy, metabolic resilience, strength, cognitive clarity, and confidence are aligned. - Vayas360 said it serves consumers, patients, practitioners, employers, and payer partners across metabolic and cardiometabolic health, GLP-1 nutritional support, gut and microbiome health, longevity, and women’s health. - The company’s acquisition strategy is aimed at building the operational layers behind that model, including testing, therapeutic nutrition, supplementation, wearable integration, coaching, and payer-aligned care pathways. - Vayas360’s website is More information. - AND Capital Ventures describes itself as an AI-native, operator-led global investment and growth capital platform focused on healthcare innovation, health and wellness, real assets, and energy transition. - AND Capital Ventures said its health and wellness strategy targets companies that increase healthspan, improve outcomes, and expand care capacity. - The firm operates with team members across Calgary, Austin, New York, Boston, and London.

Between the lines: - Vayas360 is positioning itself around systems-based personalized care, a model that mirrors the functional medicine audience gathered at the San Diego conference. - The company’s pitch is that durable health outcomes will come from connecting clinical insight, nutrition, biometrics, and ongoing monitoring instead of selling disconnected tools. - AND Capital Ventures appears to be backing a platform thesis rather than a point solution thesis, which fits the company’s stated focus on operationally complex businesses. - The emphasis on payer relationships and accredited programs suggests Vayas360 is trying to build a model that can work across consumer, clinical, and reimbursement channels.

What’s next: - Vayas360 said the commitment is expected to help complete the first close of the current raise. - The company said it is continuing toward the acquisition of the medically tailored nutrition operator. - Vayas360 said future transactions will help assemble the rest of the ecosystem behind its personalized health platform. - Forward-looking statements in the release note that financing, closing timelines, acquisition activity, and platform development remain subject to risks and uncertainties.

The bottom line: - Vayas360 is using its first major capital commitment to buy its way into a larger personalized health platform built around diagnostics, nutrition, and longitudinal data.